McRae Capital Management’s Labcorp LH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $22.7M | Sell |
81,089
-2,386
| -3% | -$627K | 4.47% | 4 |
|
|
2026
Q1 | $22.3M | Sell |
83,475
-1,222
| -1% | -$331K | 4.62% | 2 |
|
|
2025
Q4 | $21.2M | Buy |
84,697
+226
| +0.3% | +$60K | 4.34% | 5 |
|
|
2025
Q3 | $24.2M | Sell |
84,471
-920
| -1% | -$246K | 4.81% | 4 |
|
|
2025
Q2 | $22.4M | Sell |
85,391
-510
| -0.6% | -$124K | 4.59% | 5 |
|
|
2025
Q1 | $20M | Buy |
85,901
+1,455
| +2% | +$353K | 4.21% | 7 |
|
|
2024
Q4 | $19.4M | Buy |
84,446
+1,295
| +2% | +$297K | 3.8% | 9 |
|
|
2024
Q3 | $18.6M | Buy |
83,151
+764
| +0.9% | +$168K | 3.63% | 10 |
|
|
2024
Q2 | $16.8M | Buy |
82,387
+2,639
| +3% | +$537K | 3.82% | 10 |
|
|
2024
Q1 | $17.4M | Buy |
79,748
+5,836
| +8% | +$1.29M | 3.82% | 10 |
|
|
2023
Q4 | $16.8M | Buy |
73,912
+3,331
| +5% | +$700K | 4.2% | 9 |
|
|
2023
Q3 | $14.2M | Sell |
70,581
-11,095
| -14% | -$2.34M | 4.2% | 7 |
|
|
2023
Q2 | $16.9M | Buy |
81,676
+537
| +0.7% | +$104K | 4.81% | 5 |
|
|
2023
Q1 | $16M | Buy |
81,139
+3,028
| +4% | +$623K | 4.6% | 5 |
|
|
2022
Q4 | $15.8M | Sell |
78,111
-1,827
| -2% | -$357K | 4.62% | 3 |
|
|
2022
Q3 | $14.1M | Buy |
79,938
+642
| +0.8% | +$131K | 4.28% | 5 |
|
|
2022
Q2 | $16M | Sell |
79,296
-351
| -0.4% | -$74.8K | 4.33% | 5 |
|
|
2022
Q1 | $18M | Sell |
79,647
-436
| -0.5% | -$103K | 4.07% | 3 |
|
|
2021
Q4 | $21.6M | Buy |
80,083
+687
| +0.9% | +$170K | 4.51% | 4 |
|
|
2021
Q3 | $19.2M | Sell |
79,396
-82
| -0.1% | -$20.7K | 4.23% | 4 |
|
|
2021
Q2 | $18.8M | Sell |
79,478
-984
| -1% | -$224K | 4.31% | 3 |
|
|
2021
Q1 | $17.6M | Buy |
80,462
+1,269
| +2% | +$255K | 4.37% | 5 |
|
|
2020
Q4 | $13.8M | Sell |
79,193
-553
| -0.7% | -$95.5K | 3.97% | 5 |
|
|
2020
Q3 | $12.9M | Sell |
79,746
-349
| -0.4% | -$55.3K | 4.32% | 4 |
|
|
2020
Q2 | $11.4M | Buy |
80,095
+437
| +0.5% | +$60.5K | 4.28% | 4 |
|
|
2020
Q1 | $8.65M | Buy |
79,658
+1,658
| +2% | +$239K | 4.22% | 5 |
|
|
2019
Q4 | $11.3M | Buy |
78,000
+1,100
| +1% | +$159K | 4.18% | 5 |
|
|
2019
Q3 | $11.1M | Buy |
76,900
+227
| +0.3% | +$33.1K | 4.33% | 4 |
|
|
2019
Q2 | $11.4M | Buy |
76,673
+611
| +0.8% | +$85.3K | 4.56% | 4 |
|
|
2019
Q1 | $10M | Buy |
76,062
+2,631
| +4% | +$324K | 4.16% | 6 |
|
|
2018
Q4 | $7.97M | Buy |
73,431
+1,385
| +2% | +$186K | 4.1% | 7 |
|
|
2018
Q3 | $10.8M | Buy |
72,046
+3,667
| +5% | +$558K | 4.56% | 6 |
|
|
2018
Q2 | $10.5M | Sell |
68,379
-233
| -0.3% | -$35.2K | 4.41% | 4 |
|
|
2018
Q1 | $9.53M | Sell |
68,612
-1,647
| -2% | -$242K | 4.31% | 5 |
|
|
2017
Q4 | $9.63M | Buy |
70,259
+1,048
| +2% | +$138K | 4.06% | 8 |
|
|
2017
Q3 | $8.98M | Sell |
69,211
-2,881
| -4% | -$384K | 3.86% | 7 |
|
|
2017
Q2 | $9.55M | Buy |
72,092
+2,619
| +4% | +$321K | 3.87% | 8 |
|
|
2017
Q1 | $8.56M | Buy |
69,473
+3,695
| +6% | +$438K | 3.53% | 10 |
|
|
2016
Q4 | $7.25M | Buy |
65,778
+3,370
| +5% | +$374K | 3.2% | 13 |
|
|
2016
Q3 | $7.37M | Buy |
62,408
+3,155
| +5% | +$372K | 3.35% | 12 |
|
|
2016
Q2 | $6.63M | Buy |
+59,253
| New | +$6.38M | 3.07% | 15 |
|
Other funds holding LH
McRae Capital Management's LH Position: Q2 2026 in Review
McRae Capital Management reduced its Labcorp (LH) stake by 2.9% in Q2 2026, selling an estimated $627K and leaving 81,089 shares worth $22.7M. The position accounts for 4.47% of the portfolio, ranked #4.
McRae Capital Management first reported a position in LH in Q2 2016 and has held it in 41 quarters since. The position peaked at $24.2M in Q3 2025. 1,051 funds tracked by Wall St. Rank hold LH as of Q2 2026.
- McRae Capital Management held 81,089 shares of Labcorp worth $22.7M as of Q2 2026.
- McRae Capital Management sold 2,386 Labcorp shares in Q2 2026, an estimated $627K.
- Labcorp made up 4.47% of McRae Capital Management's portfolio in Q2 2026, its #4 holding.
- McRae Capital Management first reported a position in Labcorp in Q2 2016 and has held it in 41 quarters since.
- McRae Capital Management's Labcorp position peaked at $24.2M in Q3 2025.
- 1,051 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.
Based on McRae Capital Management's 13F filing for Q2 2026, filed 17 Jul 2026.